Valeos Pharma A/S: Financial statements 2020
CVR: 39696614
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,276,838 and a net result of DKK -1,704,956. Equity in the 2020 report amounted to DKK -1,416,231. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,276,838
- Profit/Loss
- DKK -1,704,956
- Equity
- DKK -1,416,231
- Total Assets
- DKK 22,247,291
- Employees
- 2
Official annual report
How creditworthy is Valeos Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Valeos Pharma A/S has published its interim report for the period July 3, 2018 to December 31, 2019.
On March 10, 2020, the company changed its name from Valeos ApS to Valeos A/S.
About Valeos Pharma A/S
Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.